Frank Diamond
Managing Editor
MANAGED CARE March 2011. ©MediMedia USA

Blue Cross & Blue Shield of Minnesota hopes that adding weight maintenance to its tobacco program will bolster results

Managing Editor

Mark Twain wrote, “Giving up smoking is the easiest thing in the world. I know because I’ve done it thousands of times.” Was Twain worried about weight gain? Because medical managers at Blue Cross & Blue Shield of Minnesota have decided that that’s one of the main reasons people often can’t quit.

Marc Manley, MD, the plan’s chief prevention officer, says that the insurer has offered its stop-smoking support program since 2000 and that he and his team are continually evaluating the service. In January, it launched a smoking cessation/weight loss program. “We try to remove whatever barriers people are facing,” he says.

The health plan uses trained “quit coaches” who develop tactics geared to the individual, says Manley. Members who enroll in the program also receive access to around-the-clock online support by way of a tool the plan calls “Web coach.” The critical time appears to be the first six months. “The hardest time is right after they quit. That’s really when they need the most support.”

“Members who enroll can call back for more support between 7 a.m. and 11 p.m. seven days a week,” says Manley. “The whole impetus for this is just to help people get through that time of quitting successfully and make it so that they have every resource — so that their concerns about gaining weight are addressed.”

Mary Kate Salley is the senior vice president for client services at Free & Clear, the vendor running Blue Cross & Blue Shield of Minnesota’s smoking cessation/weight loss program.

“Historically, programs focus on quitting smoking and imply that the patients shouldn’t worry all that much about weight gain,” says Salley. The medical literature reports that smokers do indeed gain weight — from 8 to 20 pounds. “So, particularly for women, that could be an issue,” says Salley. “But the added support that we have means that they are able to quit and either maintain their weight or gain less weight than those who received only the initial smoking-cessation support.”

While Free & Clear contracts with employers to provide its service, Blue Cross & Blue Shield of Minnesota is the only health plan it contracts with so far.

According to surveys, Minnesota’s smoking rate has declined from 22 percent in 1999 to 16.1 in 2011. (The newest survey was just released in mid-February. See it at www.mnadulttobaccosurvey.org.) Don’t celebrate just yet, because statistics show that 625,000 Minnesota adults still smoke, as do 56,000 Minnesota high school students. (The information on youth smoking is from a study conducted by the state Department of Health.)

Metabolism

Part of the research done by Blue Cross & Blue Shield of Minnesota involved investigating the long-pondered question of why people tend to gain weight when they quit smoking. “Not everybody gains weight. For most people who do gain weight, it’s only a few pounds,” says Manley. “It’s much healthier to gain a few pounds than to keep smoking.”

That said, people who stop smoking gain weight for different reasons, Manley continues. “Nicotine actually does have some impact on the body’s rate of metabolism. So when people don’t have as much nicotine in their system, their metabolism slows down a little.

“Some people may eat more. If they’re feeling uncomfortable because they’re used to having a cigarette in their mouth, some people substitute eating.”

“Here in Minnesota smoking is costing about $2.87 billion a year just in health care costs,” says Marc Manley, MD, the chief prevention officer for Blue Cross & Blue Shield of Minnesota.

Managed Care’s Top Ten Articles of 2016

There’s a lot more going on in health care than mergers (Aetna-Humana, Anthem-Cigna) creating huge players. Hundreds of insurers operate in 50 different states. Self-insured employers, ACA public exchanges, Medicare Advantage, and Medicaid managed care plans crowd an increasingly complex market.

Major health care players are determined to make health information exchanges (HIEs) work. The push toward value-based payment alone almost guarantees that HIEs will be tweaked, poked, prodded, and overhauled until they deliver on their promise. The goal: straight talk from and among tech systems.

They bring a different mindset. They’re willing to work in teams and focus on the sort of evidence-based medicine that can guide health care’s transformation into a system based on value. One question: How well will this new generation of data-driven MDs deal with patients?

The surge of new MS treatments have been for the relapsing-remitting form of the disease. There’s hope for sufferers of a different form of MS. By homing in on CD20-positive B cells, ocrelizumab is able to knock them out and other aberrant B cells circulating in the bloodstream.

A flood of tests have insurers ramping up prior authorization and utilization review. Information overload is a problem. As doctors struggle to keep up, health plans need to get ahead of the development of the technology in order to successfully manage genetic testing appropriately.

Having the data is one thing. Knowing how to use it is another. Applying its computational power to the data, a company called RowdMap puts providers into high-, medium-, and low-value buckets compared with peers in their markets, using specific benchmarks to show why outliers differ from the norm.
Competition among manufacturers, industry consolidation, and capitalization on me-too drugs are cranking up generic and branded drug prices. This increase has compelled PBMs, health plan sponsors, and retail pharmacies to find novel ways to turn a profit, often at the expense of the consumer.
The development of recombinant DNA and other technologies has added a new dimension to care. These medications have revolutionized the treatment of rheumatoid arthritis and many of the other 80 or so autoimmune diseases. But they can be budget busters and have a tricky side effect profile.

Shelley Slade
Vogel, Slade & Goldstein

Hub programs have emerged as a profitable new line of business in the sales and distribution side of the pharmaceutical industry that has got more than its fair share of wheeling and dealing. But they spell trouble if they spark collusion, threaten patients, or waste federal dollars.

More companies are self-insuring—and it’s not just large employers that are striking out on their own. The percentage of employers who fully self-insure increased by 44% in 1999 to 63% in 2015. Self-insurance may give employers more control over benefit packages, and stop-loss protects them against uncapped liability.